[Articles] Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study

In patients with BRAFV600-mutated melanoma with CNS metastases, atezolizumab along with vemurafenib and cobimetinibus provided intracranial activity.